Caris Life Sciences, Inc. (CAI)
27.10
-0.05
(-0.18%)
USD |
NASDAQ |
Dec 10, 16:00
27.17
+0.07
(+0.26%)
After-Hours: 20:00
Caris Life Sciences Shareholders Equity (Quarterly): 478.36M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| TransMedics Group, Inc. | 355.20M |
| AbbVie, Inc. | -2.642B |
| DexCom, Inc. | 2.726B |
| BioLife Solutions, Inc. | 353.74M |
| Phibro Animal Health Corp. | 311.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 984.57M |
| Total Liabilities (Quarterly) | 506.21M |
| Debt to Equity Ratio | 0.8921 |
| Current Ratio | 9.930 |
| Net Debt Paydown Yield | -1.00% |